Beta-cell replacement in immunosuppressed recipients: Old and new clinical indications

Acta Diabetologica

Volumn 44, Issue 4, 2007, Pages 171-176

  Bertuzzi, Federico ^a,b   Ricordi, Camillo ^c  

^a MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Hemosiderosis; Islet transplantation; Mucoviscidosis; Secondary diabetes mellitus; Type 1 diabetes mellitus

Indexed keywords

CYSTIC FIBROSIS; DIABETES CONTROL; GRAFT SURVIVAL; HEPATOCYTE TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RECIPIENT; REVIEW; TREATMENT INDICATION;

ALGORITHMS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HUMANS; IMMUNOSUPPRESSION; INFUSIONS, PARENTERAL; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; WAITING LISTS;

EID: 36249030051     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0020-9     Document Type: Review

References (43)

1. Witkowski P, Zakai SB, Rana A, Sledzinski Z, Hardy MA (2006) Pancreatic islet transplantation, what has been achieved since Edmonton break-through. Ann Transplant 11:5-13
2. Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, Pileggi A, Poggioli R, Ichii H, Khan A, Ferreira JV, Pugliese A, Esquenazi VV, Kenyon NS, Alejandro R (2005) Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 5:2037-2046
3. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM (2001) Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50:710-719
4. Shapiro AM, Ricordi C, Hering B (2003) Edmonton's islet success has indeed been replicated elsewhere. Lancet 362:1242-1242
5. Venturini M, Fiorina P, Maffi P, Losio C, Vergani A, Secchi A, Del Maschio A (2006) Early increase of retinal arterial and venous blood flow velocities at color Doppler imaging in brittle type 1 diabetes after islet transplant alone. Transplantation 81:1274-1277
6. Fiorina P, Gremizzi C, Maffi P, Caldara R, Tavano D, Monti L, Socci C, Folli F, Fazio F, Astorri E, Del Maschio A, Secchi A (2005) Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care 28:1358-1365
7. Fiorina P, Venturini M, Folli F, Losio C, Maffi P, Placidi C, La Rosa S, Orsenigo E, Socci C, Capella C, Del Maschio A, Secchi A (2005) Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation. Diabetes Care 28:1303-1310
8. Luzi L, Hering BJ, Socci C, Raptis G, Battezzati A, Terruzzi I, Falqui L, Brandhorst H, Brandhorst D, Regalia E, Brambilla E, Secchi A, Perseghin G, Maffi P, Bianchi E, Mazzaferro V, Gennari L, Di Carlo V, Federlin K, Pozza G, Bretzel RG (1996) Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 97:2611-2618
9. Luzi L, Perseghin G, Brendel MD, Terruzzi I, Battezzati A, Eckhard M, Brandhorst D, Brandhorst H, Friemann S, Socci C, Di Carlo V, Piceni Sereni L, Benedini S, Secchi A, Pozza G, Bretzel RG (2001) Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 50:277-282
10. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069
11. Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG (1997) Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 46:1907-1910
12. Roep BO, Stobbe I, Duinkerken G, van Rood JJ, Lernmark A, Keymeulen B, Pipeleers D, Claas FH, de Vries RR (1999) Auto-and alloimmune reactivity to human islet allografts tranplanted into type 1 diabetic patients. Diabetes 48:484-490
13. Bosi E, Braghi S, Maffi P, Scirpoli M, Bertuzzi F, Pozza G, Secchi A, Bonifacio E (2001) Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 50:2464-2471
14. Bertuzzi F, Verzaro R, Provenzano V, Ricordi C (2007) Brittle type 1 diabetes mellitus. Curr Med Chem 14:1739-1744
15. Vantyghem MC, Press M (2007) Management strategies for brittle diabetes. Ann Endocrinol (Paris) 67:287-296
16. Schade DS, Burge MR (1995) Brittle diabetes: etiology and treatment. Adv Endocrinol Metab 6:289-319
17. Gill GV, Lucas S, Kent LA (1996) Prevalence and characteristics of brittle diabetes in Britain. QJM 89:839-843
18. Tattersall RB (1997) Brittle diabetes revisited: the Third Arnold Bloom Memorial Lecture. Diabet Med 14:99-110
19. Williams G, Pickup JC (1998) The natural history of brittle diabetes. Diabet Res 7:13-18
20. ADA Position Statement (2004) Pancreas transplantation in type 1 diabetes. Diabet Care 27:S105
21. Sutherland DE, Gruessner A, Hering BJ (2004) Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach. Endocrinol Metab Clin North Am 33:135-148
22. Bretzel RG, Brendel M, Eckhard M, Brandhorst D, Jaeger C, Hatziagelaki E, Federlin K (2001) Islet transplantation: present clinical situation and future aspects. Exp Clin Endocrinol Diabetes 109(Suppl 2):S384-S399
23. Bertuzzi F, Grohovaz F, Maffi P, Caumo A, Aldrighetti L, Nano R, Hengster P, Calori G, Di Carlo V, Bonifacio E, Secchi A (2002) Successful transplantation of human islets in recipients bearing a kidney graft. Diabetologia 45:77-84
24. Fiorina P, Folli F, Bertuzzi F, Maffi P, Finzi G, Venturini M, Socci C, Davalli A, Orsenigo E, Monti L, Falqui L, Uccella S, La Rosa S, Usellini L, Properzi G, Di Carlo V, Del Maschio A, Capella C, Secchi A (2002) Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabet Care 26:1129-1136
25. Tzakis AG, Ricordi C, Alejandro R, Zeng Y, Fung JJ, Todo S, Demetris AJ, Mintz DH, Starzl TE (1990) Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet 336:402-405
26. Carroll PB, Rilo HL, Alejandro R, Zeng Y, Khan R, Fontes P, Tzakis AG, Carr B, Ricordi C (1995) Long-term (>3-year) insulin independence in a patient with pancreatic islet cell transplantation following upper abdominal exenteration and liver replacement for fibrolamellar hepatocellular carcinoma. Transplantation 59:875-879
27. Tschopp JM, Brutsche MH, Frey JG, Spiliopoulos A, Nicod L, Rochat T, Morel P (1997) End-stage cystic fibrosis: improved diabetes control 2 years after successful isolated pancreatic cell and double-lung transplantation. Chest 112:1685-1687
28. Cretin N, Buhler L, Fournier B, Caulfield A, Oberholzer J, Becker C, Phillippe J, Morel P (1998) Results of human islet allotransplantation in cystic fibrosis and type I diabetic patients. Transplant Proc 30:315-316
29. Salvadori M, Bertoni E, Rosati A, Zanazzi M (2003) Post-transplant diabetes mellitus. J Nephrol 16:626-634
30. Burroughs TE, Lentine KL, Takemoto SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish WD, Schnitzler MA (2007) Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clin J Am Soc Nephrol 2:517-523
31. Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR, Kim SK (2006) Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 443:345-349
32. Penfornis A, Kury-Paulin S (2006) Immunosuppressive drug-induced diabetes. Diabetes Metab 32:539-546
33. Faradji RN, Monroy K, Messinger S, Pileggi A, Froud T, Baidal DA, Cure PE, Ricordi C, Luzi L, Alejandro R (2007) Simple measures to monitor beta-cell mass and assess islet graft dysfunction. Am J Transplant 7:303-308
34. Bretzel RG, Brandhorst D, Brandhorst H, Eckhard M, Ernst W, Friemann S, Rau W, Weimar B, Rauber K, Hering BJ, Brendel MD (1999) Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management. J Mol Med 77:140-143
35. Secchi A, Socci C, Maffi P, Taglietti MV, Falqui L, Bertuzzi F, De Nittis P, Piemonti L, Scopsi L, Di Carlo V, Pozza G (1997) Islet transplantation in IDDM patients. Diabetologia 40:225-231
36. Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey J, Hunter DW, Sutherland DE (2005) Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293:830-835
37. Kamada N, Davies HS, Roser B (1981) Reversal of transplantation immunity by liver grafting. Nature 292:840-842
38. Sawada T, Asanuma Y, Furuya T, Saito K, Koyama K (1999) Tolerance of islet allografts induced by orthotopic liver transplantation. J Surg Res 85:209-216
39. Wang XY, Sun J, Wang C, France M, Sheil AG (2001) Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance. Transplantation 71:102-111
40. Venturini M, Angeli E, Maffi P, Fiorina P, Bertuzzi F, Salvioni M, De Cobelli F, Socci C, Aldrighetti L, Losio C, Di Carlo V, Secchi A, Del Maschio A (2005) Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US. Radiology 234:617-624
41. Conget I, Piquer S, Julià M, Gomis R, Esmatjes E, García-Pagán JC, Bosch J, Gilabert R, Ricart MJ, Fernández-Cruz L, Manyalich M (2006) Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route. Transplantation 81:1220-1221
42. Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Kallen R, Ostraat O, Salmela K, Tibell A, Tufveson G, Elgue G, Nilsson Ekdahl K, Korsgren O, Nilsson B (2002) Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360:2039-2045
43. White SA, Davies JE, Pollard C, Swift SM, Clayton HA, Sutton CD, Weymss-Holden S, Musto PP, Berry DP, Dennison AR (2001) Pancreas resection and islet autotransplantation for end-stage chronic pancreatitis. Ann Surg 233:423-431